Sohaja Implant Plus Tablets and Gas n Free Zhu Tablets

Hanmi Pharmaceutical is expanding its lineup of over-the-counter digestive medicines, allowing consumers to choose products based on symptoms such as indigestion and abdominal bloating.

Product image of Sohaja Implus Jeong and Gas & Prechu Jeong. Hanmi Pharmaceutical

Product image of Sohaja Implus Jeong and Gas & Prechu Jeong. Hanmi Pharmaceutical

View original image

On September 30, Hanmi Pharmaceutical announced that it is supplying the combination digestive product “Sohaja Implant Plus Tablets” and the intestinal gas remover “Gas n Free Zhu Tablets” to pharmacies nationwide.


Sohaja Implant Plus Tablets is a combination digestive containing eight ingredients that aid digestion. Recently, in addition to the existing 10-tablet package, a 30-tablet pack has also been launched. The product targets not only those with occasional overeating or indigestion, but also consumers seeking to keep household medicines on hand.


For discomfort caused by abdominal bloating or intestinal gas, Gas n Free Zhu Tablets can be used. This is an over-the-counter medicine containing only simethicone, which helps relieve discomfort such as abdominal bloating and aerophagia by removing intestinal gas. It is a chewable mint-flavored tablet that can be taken without water, making it convenient to carry.


A Hanmi Pharmaceutical official stated, "After holiday breaks, many people experience indigestion or abdominal bloating due to eating larger amounts of food than usual," adding, "We are building an over-the-counter product lineup to enable symptom-specific management, from indigestion to abdominal bloating caused by intestinal gas."



Sohaja Implant Plus Tablets and Gas n Free Zhu Tablets are supplied to pharmacies across the country through OnlinePharm, a subsidiary of Hanmi Science. They are available for purchase without a prescription.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing